Ideally, tumour-derived Wnt5 signaling induces activates β-catenin in tumour-associated DCs (TADC), causing secretion of indoleamine 2,3-dioxygenase (IDO), which promotes the generation of Treg cells to suppress anti-tumour T cell activity (109, 110). The gene discussed is IDO1; the disease is neoplasm.